TOP SYLO TOKEN SECRETS

Understanding OUR Cytokine-Based Immunotherapy Candidates Our dedication extends to advancing a robust portfolio of programs directed at expanding the horizons of cytokine-based immunotherapy, specifically for cancers where therapy options remain limited. Make use of the links below to learn more about our portfolio of cytokine-based immunotherapy